Faculty Profile: Jennifer Tidey, PHD

Jennifer Tidey
Jennifer Tidey, PHD
Associate Professor of Psychiatry & Human Behavior (Research)
Bio Med Alcohol & Addiction, Psychiatry & Human Behavior
Work: +1 401-863-6418
Jennifer Tidey studies biological, environmental and social factors that contribute to the high rates of cigarette smoking, particularly among people with serious mental illness, in order to inform regulatory and treatment approaches to reducing tobacco and other substance use disorders.

Biography

Jennifer Tidey is a Research Associate Professor in the Department of Psychiatry and Human Behavior at Brown Medical School and the Department of Behavioral and Social Sciences at Brown University's School of Public Health. She is a core and training faculty member of Brown University's Center for Alcohol and Addictions Studies (CAAS). Trained as a behavioral pharmacologist at Tufts University, she completed post-graduate training at Harvard University and the University of Vermont before coming to Brown in 1999. Her primary research area is the identification of biological and environmental mechanisms that contribute to the high rates of cigarette smoking among people with serious mental illness. She is the Director of the CAAS Addictive Behaviors Laboratory, an Associate Director of the CAAS NIDA T32 Post-doctoral Training program, and an Associate Editor for the journal Nicotine & Tobacco Research.

Institutions

Bh

Research Description

Jennifer Tidey is a core and training faculty member of Brown University's Center for Alcohol and Addictions Studies (CAAS). Her primary research area is the identification of biological and environmental factors that contribute to the high rates of cigarette smoking among people with serious mental illness. A substantial portion of her current research effort focuses on tobacco control regulatory science – in particular, studies aimed at understanding how marked reductions in the nicotine content of cigarettes may affect cigarette use in smokers with serious mental illness. She is the Principal Investigator of two studies in this area, one in smokers with schizophrenia and one in smokers with major depressive disorder, and the co-investigator on a study in smokers sampled from the general population. These studies are part of multi-site tobacco regulatory control research centers. In addition, she collaborates with numerous CAAS faculty on studies aimed at understanding and treating tobacco and other substance use disorders in a variety of populations. At Brown University, she is the Director of the CAAS Addictive Behaviors Laboratory and an Associate Director of the CAAS NIDA T32 Post-doctoral Training program. She serves an Associate Editor for the journal Nicotine & Tobacco Research.

Grants and Awards

Masters of Arts ad eundem (honorary degree), Brown University, Providence, RI, 2010
Early Career Investigator Award, College on Problems of Drug Dependence, 1997
Senator Proctor Research Award, American Lung Association of Vermont, 1998
Director's Travel Award, National Institute on Drug Abuse (NIDA), 1999
Research Excellence Award, Center for Alcohol and Addiction Studies, Brown University, 2000, 2002, 2007
Memorial Travel Fellow, American College of Neuropsychopharmacology (ACNP), 2002
Service Award, Society for Research on Nicotine and Tobacco (SRNT), 2006

Affiliations

College on Problems of Drug Dependence (CPDD), 2002 – present
--CPDD Membership Committee 2013 - present
--CPDD Human Research Committee 2010 - 2013
--CPDD Program Committee 2007 - 2010
--CPDD Travel Awards and Mentoring Committee, 2002 – 2007

Society for Research on Nicotine and Tobacco (SRNT), 2000 – present
--SRNT Conference Program Co-Chair, 2005-2006
Behavioral Pharmacology Society, 1992 – present
International Study Group Investigating Drugs as Reinforcers, 1996 – present
Research Society on Alcoholism, 2001 – present

Funded Research

CURRENT GRANT SUPPORT
1. Vermont Center on Tobacco Regulatory Sciences (1P50 DA036114)
Project 3: Low Nicotine Content Cigarettes in Vulnerable Populations: Currently Depressed
Sponsor: National Institute on Drug Abuse
Center Principal Investigator: Stephen T. Higgins, Ph.D.
Project period: September 2013 – August 2018
Role: Principal Investigator of Project 3

2. Evaluating New Nicotine Standards for Cigarettes (U54 DA031659)
Project 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes
Sponsor: National Institute on Drug Abuse
Center Co-Principal Investigators: Eric Donny, Ph.D., Dorothy Hatsukami, Ph.D.
Project period: September 2011 – March 2014
Role: Site Principal Investigator

3. Evaluating New Nicotine Standards for Cigarettes (U54 DA031659)
Project 3: Very Low Nicotine Cigarettes in Smokers with Schizophrenia
Sponsor: National Institute on Drug Abuse
Project period: March 2014 – August 2016
Role: Principal Investigator

4. Vermont Center on Behavior, Incentives and Health (1P20 GM103644)
Sponsor: National Institute on Drug Abuse
Center Principal Investigator: Stephen T. Higgins, Ph.D.
Project period: September 2013 – August 2018
Role: Site Principal Investigator

5. Acute Effects of Exercise in Smokers with Schizophrenia (R21 DA031283)
National Institute on Drug Abuse
February 2012 – January 2014
Role: Principal Investigator

6. Very Low Nicotine Cigarettes in Smokers with SUD: Smoking, Substance Use Effects(1R01 DA034628)
Sponsor: National Institute on Drug Abuse
Principal Investigator: Damaris Rohsenow, Ph.D.
Project period: September 2013 – August 2018
Role: Co-Investigator

7. Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms (R01 AA007850)
National Institute on Alcohol Abuse and Alcoholism
Principal Investigator: Robert Miranda, Jr., Ph.D.
Project period: September 2011– August 2016
Role: Co-Investigator

8. Varenicline and Motivational Advice for Smokers with SUD (R01 DA024652)
National Institute on Drug Abuse
Principle Investigator: Damaris Rohsenow, Ph.D.
Project period: June 2008 – March 2014
Role: Co-Principal Investigator

9. Contingent Vouchers for Smoking in Substance Abusers as Adjunct to Nicotine Patch (R01 DA023995)
Sponsor: National Institute on Drug Abuse
Principal Investigator: Damaris Rohsenow, Ph.D.
Project period: July 2008 – May 2014
Role: Co-Investigator

Teaching Experience

T-32 NIAAA/NIDA Postdoctoral Fellowship Seminars, Brown University CAAS "How to give an effective presentation" (2003), "Responding to pink sheets" (2001-2013), "Neurobiology Seminar Series: Behavioral pharmacology of opiates, cocaine, nicotine, and everything else" (2002-2005), "Neurobiology Seminar Series: Pharmacotherapy for dependence on nicotine, cocaine or opiates" (2003-2005), "Contingency management interventions" (2002-2004), "Studying smokers with schizophrenia in the human behavioral pharmacology laboratory" (2003), "Tips for IRB success" (2004-2005), Internal reviewer of post-doctoral fellow grant applications (2003-2013)

"Neurobiology and psychopharmacology of stimulants, nicotine and cross-addictions." (Feb 2003, Feb 2004, Feb 2005, Feb 2006). Seminar for course entitled Alcohol Use and Misuse.
"Biological and behavioral effects of nicotine" (Feb 2007). Seminar for course entitled Tobacco, Smoking, and the Evil Empire.
"Neurobiology and psychopharmacology of alcohol's effects" (Feb 2008, Feb 2010). Seminar for course entitled Alcohol Use and Misuse.